Teramachi et al. reported that inhibition of TGF-β-activated kinase-1 using LLZ1640-2 reduces VCAM-1 expression in BMSCs and impairs MM cell adhesion to BMSCs [45]. This evidence concerns the gene VCAM1 and Miyoshi myopathy.